ストックスクリーナーアプリを入手
8.76
0.69%
0.06
アフターアワーズ：
8.75
-0.010
-0.11%
Organon Co (OGN) 最新ニュース
India’s Sun Pharma weighs $10 bln bid for US-listed Organon, ET reports - Investing.com
Sun Pharma Evaluates $10 Billion Acquisition of US-Based Organon - scanx.trade
Sun Pharma looks to rise in US with $10 billion Organon buy - The Economic Times
Organon (OGN) Receives FDA Approval for Nexplanon Label Expansion to 5 Years - Intellectia AI
Organon wins FDA nod to expand use of Nexplanon birth control implant - Seeking Alpha
Organon Announces US Food and Drug Administration Approval of Supplemental New Drug Application Exte - PharmiWeb.com
Organon Announces US Food and Drug Administration Approval of Supplemental New Drug Application Extending Duration of Use of NEXPLANON® (etonogestrel implant) 68 mg Radiopaque - The AI Journal
Birth control implant Nexplanon now approved to last 5 years in US - Stock Titan
About Us - FinancialContent
Organon (OGN) Receives FDA Approval to Extend NEXPLANON Use to 5 Years - Intellectia AI
Organon (OGN) Receives FDA Approval for NEXPLANON Extended Use Up to 5 Years - Intellectia AI
Performance Recap: Whats the beta of Organon Co stockJuly 2025 Earnings & Detailed Earnings Play Alerts - baoquankhu1.vn
Global Organon employees on leading Pride Network and building inclusive workplaces - attitude.co.uk
Earnings Recap: Whats the beta of Organon Co stockLong Setup & Daily Chart Pattern Signals - baoquankhu1.vn
OGNORGANON & CO Latest Stock News & Market Updates - Stock Titan
Organon (OGN) Increases Despite Market Slip: Here's What You Need to Know - sharewise.com
Organon (OGN) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance
Organon and Co put volume heavy and directionally bearish - TipRanks
Nordea Investment Management AB Has $31.71 Million Position in Organon & Co. $OGN - MarketBeat
Validea Kenneth Fisher Strategy Daily Upgrade Report2/14/2025 - Intellectia AI
Organon & Co. (OGN) Stock Analysis: Exploring a 15% Potential Upside Amidst Diverse Product Portfolio - DirectorsTalk Interviews
Aug Levels: Will Organon Co stock see PE expansionEarnings Recap Report & High Yield Equity Trading Tips - Bộ Nội Vụ
Organon Shares Show Signs of a Turnaround - AD HOC NEWS
Responsive Playbooks and the OGN Inflection - Stock Traders Daily
Short Squeeze: How Organon Co stock reacts to inflationary pressuresCPI Data & Precise Buy Zone Tips - moha.gov.vn
Organon & Co. (NYSE:OGN) Receives Average Recommendation of "Reduce" from Analysts - MarketBeat
Organon & Co. $OGN Shares Sold by Philip James Wealth Mangement LLC - MarketBeat
Why Organon (OGN) Is Up 13.4% After Expanding Nilemdo Rights In Six European Markets - Yahoo Finance
Assessing Organon (OGN) Valuation After Short Term Share Price Momentum And Long Term Weak Returns - Yahoo Finance
Organon poised to extend rally to seventh consecutive session - MSN
Assessing Organon (OGN) Valuation After New Nilemdo Cholesterol Therapy Agreement - simplywall.st
Organon, Daiichi Sankyo Europe enter commercialization pact for Nilemdo - TipRanks
Organon Enters into a Commercialization Agreement for Daiichi Sankyo's Nilemdo®? in France, Denmark, Iceland, Sweden, Finland and Norway - marketscreener.com
Organon Enters into a Commercialization Agreement for Daiichi Sankyo’s Nilemdo - Business Wire
Organon Named Top Dividend Stock With Insider Buying and 0.99% Yield (OGN) - Nasdaq
Organon & Co. (OGN) Stock Analysis: Exploring The 25.77% Potential Upside For Investors - DirectorsTalk Interviews
Is Organon (NYSE:OGN) A Risky Investment? - 富途牛牛
Organon & Co. Sees Unusually Large Options Volume (NYSE:OGN) - MarketBeat
Great week for Organon & Co. (NYSE:OGN) institutional investors after losing 51% over the previous year - simplywall.st
Organon (OGN) Surpasses Market Returns: Some Facts Worth Knowing - Yahoo Finance
Samsung Bioepis Denies Organon Deal Rumors - Citeline News & Insights
Samsung Bioepis pursues direct sales by weighing Organon acquisition to boost profitsCHOSUNBIZ - Chosunbiz
Samsung Bioepis reviews Organon acquisition to boost direct biosimilar salesCHOSUNBIZ - Chosunbiz
Mixed Martial Arts Group Limited Stock Analysis and ForecastTechnical Resistance Breaks & Stay One Step Ahead of Risk Events - earlytimes.in
Organon & Co. (NYSE:OGN) Upgraded at Wall Street Zen - MarketBeat
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know - sharewise.com
Understanding the Setup: (OGN) and Scalable Risk - Stock Traders Daily
Will Organon Co 7XP stock outperform value peersMarket Growth Report & Fast Exit and Entry Trade Guides - moha.gov.vn
Volume Summary: How Organon Co stock reacts to inflationary pressuresBreakout Watch & Expert-Curated Trade Recommendations - moha.gov.vn
Organon & Co. (OGN) Stock Analysis: A Closer Look at Its 31.61% Potential Upside and What It Means for Investors - DirectorsTalk Interviews
Does Organon’s 50% Share Price Slide Signal Opportunity in 2025? - Yahoo Finance
Gilman Hill Asset Management LLC Reduces Position in Organon & Co. $OGN - MarketBeat
Here is What to Know Beyond Why Organon & Co. (OGN) is a Trending Stock - sharewise.com
Organon (OGN) Beats Stock Market Upswing: What Investors Need to Know - sharewise.com
Why (OGN) Price Action Is Critical for Tactical Trading - news.stocktradersdaily.com
Organon: Deep Value With No Clear Catalysts (NYSE:OGN) - Seeking Alpha
Pharma co Organon inks VPPA with Schneider Electric for solar in Spain - Renewables Now
Securities Lawsuit Alert: Organon & Co. (OGN)Contact Levi & Korsinsky Before July 22, 2025 - TMX Newsfile
Organon & Co. (NYSE:OGN) Given Average Recommendation of "Reduce" by Analysts - MarketBeat
1.85%
3.01%
大文字化:
|
ボリューム (24 時間):